Neuropathic pain in breast cancer survivors: using the ID pain as a screening tool.
Neuropathic pain in breast cancer survivors: using the ID pain as a screening tool.
复制标题
DOI：
10.1016/j.jpainsymman.2009.09.020
复制
发表时间：
2010-05
影响因子：
4.7
通讯作者：
Shete, Sanjay
中科院分区：
文献类型：
--
作者：
Reyes-Gibby, Cielito;Morrow, Phuong Khanh;Bennett, Michael I.;Jensen, Mark P.;Shete, Sanjay
Neuropathic pain (NP) is a debilitating symptom experienced by a number of patients with cancer. We evaluated the validity of ID Pain as a screening tool for NP in breast cancer survivors using the S-LANSS and a reported diagnosis of NP as criterion measures. Two hundred and forty breast cancer survivors with a mean age of 58 years (SD= 16) participated in this survey. Forty-five percent of the sample reported having pain in the past week. Of those reporting pain, 33% reported that they had been diagnosed by their health care provider for NP, 39% had a positive ID Pain (≥ 2) score and 19% had a positive S-LANSS score. The most commonly endorsed ID Pain item was “hot/burning” (n = 48), followed by feeling “numb” (n = 47) and “pins and needles” (n = 45). Total ID Pain score was significantly associated with a clinical diagnosis of NP (r = 0.41; P < 0.001) and the S-LANSS total score (r = 0.54; P < 0.001). Receiver Operating Curve analysis demonstrated that ID Pain has a predictive validity of 0.72 and 0.70 for diagnosis of NP as made by clinicians and the S-LANSS, respectively. We also found that an ID Pain score of ≥ 2 corresponded with the likelihood of NP in this sample, consistent with the original ID Pain development study. This study provides evidence for ID Pain as a valid screening measure of NP for breast cancer survivors.
登录
查看更多内容
影响因子：
7.4
作者：
Rasmussen, PV;Sindrup, SH;Bach, FW
通讯作者：
Bach, FW
影响因子：
3.9
作者：
Becker, Corinne;Pham, Duc Nhat Minh;Riquet, Marc
通讯作者：
Riquet, Marc
影响因子：
2.2
作者：
Rietman, J;Dijkstra, P;de Vries, J
通讯作者：
de Vries, J
影响因子：
3.5
作者：
Amichetti, M;Caffo, O
通讯作者：
Caffo, O
影响因子：
7.4
作者：
Bennett, M
通讯作者：
Bennett, M